Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1995
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656950A1 Tat-derived transport polypeptides
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656907A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656890A1 Novel method for preparing ergothioneine
06/14/1995EP0656889A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
06/14/1995EP0656844A1 Crank mechanism for a windscreen wiper drive of a motor vehicle.
06/14/1995EP0656790A1 Compositions and methods for modulating rna
06/14/1995EP0656784A1 Parathyroid hormone fragments and analogs
06/14/1995EP0525111B1 Antiinflammatory hydroxamic acids and n-hydroxyureas
06/14/1995CN1103578A Hair restorer and its preparation
06/14/1995CN1028866C Method for preparation of methylene bis-phosphonic acid derivatives
06/13/1995US5424471 Crystalline amifostine compositions and methods of the preparation and use of same
06/13/1995US5424448 Preparation of carbonic anhydrase inhibitors
06/13/1995US5424447 Inhibitors of nitric oxide formation from arginine
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5424319 Renin inhibitors
06/13/1995US5424318 Treating dementia, cerebrovascular diseases
06/13/1995US5424312 Treating central nervous system disorders, high blood pressure
06/13/1995US5424307 Renin inhibitors
06/13/1995US5424293 Phenylimidazolidine derivatives and their use
06/13/1995US5424292 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
06/13/1995US5424208 Contacting connective tissue containing viable cells with collagenase and chymopapain to hydrolyze the connective tissue
06/08/1995WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
06/08/1995WO1995015336A1 Double-chain hemoregulatory peptides
06/08/1995WO1995015312A1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015310A1 Prolyl endopeptidase inhibitors
06/08/1995WO1995015309A1 Dp-iv-serine protease inhibitors
06/08/1995WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015167A1 In utero gene therapy for fetuses
06/08/1995CA2178066A1 Dp-iv-serine protease inhibitors
06/08/1995CA2177998A1 In utero gene therapy for fetuses
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/08/1995CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/07/1995EP0656354A1 Substituted N-piperidino 3-pyrazolecarboxamide
06/07/1995EP0656345A1 Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases
06/07/1995EP0656209A2 Melatonin derivatives for use in treating desynchronization disorders
06/07/1995EP0656207A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656206A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656201A1 Use of stimulators of glutathione synthesis as hait growth promotors
06/07/1995EP0656069A1 Inhibitors of cell proliferation, their preparation and use
06/07/1995EP0656062A1 Dorsal tissue affecting factor and compositions
06/07/1995EP0656009A1 Glycyl-hystidyle-lysine (ghl) derivatives
06/07/1995EP0656003A1 Condensed indole derivatives as 5ht2c and 5ht2b antagonists
06/07/1995EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
06/07/1995EP0655923A1 Antiangiogenic oligomers
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655918A1 Treatment of cancer with azt and alkylating or intercalating agents
06/07/1995EP0655917A1 Crystalline amifostine compositions and methods for the preparation and use of same
06/07/1995EP0655914A1 Novel compositions
06/07/1995EP0655912A1 Medicaments for the treatment or prevention of elevated intraocular pressure
06/07/1995EP0655907A1 Use of diacylolycerols for increasing the melanin content in melanocytes
06/07/1995CN1103311A Hair and beard blackening liquor
06/07/1995CN1028757C Process for preparing heterocyclic derivatives
06/07/1995CA2137213A1 Imidazopyridines
06/06/1995US5422373 Anti-atherosclerotic aryl compounds
06/06/1995US5422365 Naphthalene compounds
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422353 Tetrahydropyridine derivatives
06/06/1995US5422349 Renin inhibitors
06/06/1995US5422342 A hydrolase inhibitor comprising a protected oligopeptides for treating fibrose of lungs, liver and skins, atherosclerosis
06/06/1995US5422261 Pure, aqueous, nontoxic mixtures of proteolytic enzymes in buffered physiologically compatible electrolyte solutions
06/06/1995US5422100 Method and product for treating skin afflictions
06/06/1995CA2044795C Dermatological composition based on an aqueous phase
06/06/1995CA1335858C Polyanhydrides with improved hydrolytic degradation properties
06/06/1995CA1335816C 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives
06/06/1995CA1335813C Administration of monoamine acridines in cholinergic neuronal deficit states
06/06/1995CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
06/06/1995CA1335789C Fatty acid compositions
06/04/1995CA2137028A1 Pharmaceutical compounds
06/01/1995WO1995014785A1 Composition for the in vivo production of therapeutic products
06/01/1995WO1995014778A2 Dna sequence coding for a bmp receptor
06/01/1995WO1995014776A1 PROTEIN TYROSINE KINASES NAMED Rse
06/01/1995WO1995014709A1 Side chain fluoro substituted 3-carboxysteroids
06/01/1995WO1995014706A1 Pna-dna-pna chimeric macromolecules
06/01/1995WO1995014691A1 NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
06/01/1995WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995WO1995014681A1 Isoxazoline compounds as antiinflammatory agents
06/01/1995WO1995014680A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995WO1995014673A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
06/01/1995WO1995014670A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014669A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014667A1 Substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995WO1995014666A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995WO1995014657A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
06/01/1995WO1995014478A1 Purine compositions and methods for administration
06/01/1995WO1995014477A1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions
06/01/1995WO1995014468A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
06/01/1995WO1995014467A1 Therapeutic guanidines
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995WO1995014461A1 Therapeutic substituted guanidines
06/01/1995WO1995014436A1 A retrograde high frequency tissue splitter